Literature DB >> 31097533

CAR-T-cell neurotoxicity: hope is on the horizon.

Omar Ahmed1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31097533     DOI： 10.1182/blood-2019-03-900985

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  Intrathecal chemotherapy for management of steroid-refractory CAR T-cell-associated neurotoxicity syndrome.

Authors:  Nirav N Shah; Bryon D Johnson; Timothy S Fenske; Renju V Raj; Parameswaran Hari
Journal:  Blood Adv       Date:  2020-05-26

Review 2.  GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches.

Authors:  Frederick M Lang; Kevin M-C Lee; John R Teijaro; Burkhard Becher; John A Hamilton
Journal:  Nat Rev Immunol       Date:  2020-06-23       Impact factor: 53.106

Review 3.  Application of Chimeric Antigen Receptor T Cells in the Treatment of Hematological Malignancies.

Authors:  Weiqi Yan; Zhuojun Liu; Jia Liu; Yuanshi Xia; Kai Hu; Jian Yu
Journal:  Biomed Res Int       Date:  2020-10-01       Impact factor: 3.411

Review 4.  The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review.

Authors:  Ali Ataya; Vijaya Knight; Brenna C Carey; Elinor Lee; Elizabeth J Tarling; Tisha Wang
Journal:  Front Immunol       Date:  2021-11-22       Impact factor: 7.561

Review 5.  The signal pathways and treatment of cytokine storm in COVID-19.

Authors:  Lan Yang; Xueru Xie; Zikun Tu; Jinrong Fu; Damo Xu; Yufeng Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-07-07

Review 6.  GM-CSF: Orchestrating the Pulmonary Response to Infection.

Authors:  Thomas S McCormick; Rana B Hejal; Luis O Leal; Mahmoud A Ghannoum
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.